A Randomised, Double-blind, Placebo-controlled Trial of FOL-005 to Investigate Clinical Safety and Effect on Hair Growth in Healthy Volunteers
Phase of Trial: Phase I/II
Latest Information Update: 22 Feb 2018
At a glance
- Drugs FOL 005 (Primary)
- Indications Alopecia; Hair disorders; Hirsutism; Hypertrichosis
- Focus Adverse reactions
- Sponsors Follicum AB
- 22 Feb 2018 Results published in the Media Release
- 22 Feb 2018 According to a Follicum AB media release, this began in at the Clinical Research Center for Hair and Skin Science ("CRC") at the Charite University Hospital in Berlin, Germany.
- 29 Jul 2017 Status changed from recruiting to completed.